MARKET

PRTG

PRTG

Portage Biotech Inc
NASDAQ
0.5633
+0.0233
+4.31%
Closed 16:00 03/28 EDT
OPEN
0.5710
PREV CLOSE
0.5400
HIGH
0.6400
LOW
0.5500
VOLUME
17.07K
TURNOVER
0
52 WEEK HIGH
4.400
52 WEEK LOW
0.3400
MARKET CAP
11.14M
P/E (TTM)
-0.0708
1D
5D
1M
3M
1Y
5Y
Press Release: Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares Company generated approximately $2.8M of non-dilutive funding to extend cash runway. Portage is a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination.
Dow Jones · 2d ago
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Barchart · 3d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Stoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market cap stands at $515.7 million. OpGen shares moved upwards by 66.61% as the Q4 earnings report came out today.
Benzinga · 3d ago
Weekly Report: what happened at PRTG last week (0318-0322)?
Weekly Report · 4d ago
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
FactSet Research Systems Inc. Shares dipped 5.2% to $462.36 on Thursday. The company reported worse-than-expected second-quarter revenue and issued FY24 guidance. Other stocks moving in the mid-day session include Bioscience, Inc. And Kaival Brands Innovations Group.
Benzinga · 03/21 18:39
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Peraso Inc. Fell sharply after the company reported worse-than-expected fourth-quarter EPS results. Ontrak, Inc. Shares climbed 197.8% to $0.5660 in Tuesday's mid-day session. Fusion Pharmaceuticals Inc. Gained 97.3% after agreeing to be acquired by AstraZeneca.
Benzinga · 03/19 17:48
Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Shares of Fusion Pharmaceuticals Inc. Rose sharply in today's pre-market trading. The company agreed to be acquired by AstraZeneca for around $2 billion in cash. Ontrak, Inc. Shares rose 84.2% to $0.35 in pre- market trading.
Benzinga · 03/19 12:10
Weekly Report: what happened at PRTG last week (0311-0315)?
Weekly Report · 03/18 10:47
More
About PRTG
Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is advancing therapies to improve long-term treatment response and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s portfolio consists of six diverse platforms, with programs including invariant natural killer T cell (iNKT) agonists, which includes PORT-2 and PORT-3, therapies that activate the innate and adaptive immune system. The Company’s portfolio also includes small molecule adenosine inhibitors, such as PORT-6, PORT-7, PORT-8 and PORT-9, which represent of targeting the adenosine pathway. Within these six platforms, the Company has 14 products in development with multiple clinical readouts.

Webull offers Portage Biotech Inc stock information, including NASDAQ: PRTG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRTG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRTG stock methods without spending real money on the virtual paper trading platform.